Authors: Aziz Langah , Muhammad Nadeem Chohan, Abdul Hameed Radhan
Abstract
To compare the defervescence period of azithromycin versus ceftriaxone in children with enteric fever Study Design: Randomised Controlled trial. Setting And Duration: Department of Paediatrics, Federal Government Polyclinic (PGMI), Islamabad. 6 months from 30th June 2014 till 30th December 2014. Subjects: 100 patients: 50 in each respective treatment group i.e. Group A (Azithromycin) and Group B (Ceftriaxone). Method: Out of the 100 patients, 50 placed in Group A were randomly assigned to receive oral azithromycin suspension/capsule (10mg/kg/day; maximum dose, 500mg/day) administered once daily for 7 days and Group B with Intravenous (I/V) ceftriaxone (75mg/ kg/day; maximum dose, 2.5 g/day) administered twice daily for 10 days. The Clinical response to the therapy of both drugs was calculated in terms of number of days taken for defervescence. Results: Patients on Azithromycin had the mean time of defervescence 4.08 days ± S.D 0.922 and for patients on ceftriaxone; mean time of defervescence was 4.06 days ± S.D 1.038. There was no statistically significant difference (p=0.919) between the two groups, thus signifying equal efficacy of both drugs. Conclusion: Oral Azithromycin and Intravenous Ceftriaxone are equal in efficacy, for the treatment of Enteric Fever in children. Azithromycin could be a suitable alternative owing to its convenient dosing, which could be monitored on outpatient basis.
Keywords: Typhoid fever, enteric fever, Ceftriaxone, Azithromycin, efficacy, treatment outcome
